Disclosed are humanized antibodies that bind specifically to the receptor CXCR3. The humanized antibodies may be antagonists and may be used to treat or diagnose conditions associated with CXCR3 function.
申请公布号
US2013274447(A1)
申请公布日期
2013.10.17
申请号
US201313857854
申请日期
2013.04.05
申请人
TEVA BIOPHARMACEUTICALS USA, INC.;TEVA BIOPHARMACEUTICALS USA, INC.